ArticleIranian journal of pharmaceutical research : IJPR2019

FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy.

Hakimeh Zali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.